The Programme was inaugurated in the presence of Dr H S Ballal, Pro Chancellor, MAHE; Dr Sharath K. Rao, Vice Chancellor, MAHE; Mr Chandru Iyer, British Deputy High Commissioner to Karnataka and British Deputy Trade Commissioner for Investment, South Asia; and Dr Mrutyunjay Suar, Chairman, Bhubaneswar City Knowledge Innovation Cluster Foundation (BCKIC) on Wednesday.
Reflecting on the success of the programme, Chandru Iyer, British Deputy High Commissioner to Karnataka, said: "The MAHE accelerator has been three days of innovation in action, connecting Indian innovators with the UK’s healthcare, research, investment and innovation ecosystem to build international partnerships and expand their global footprint. With the recently implemented UK-India Free Trade Agreement and Double Contribution Convention creating new opportunities for innovation-led enterprises, cross-border investments, professional mobility and deeper collaboration, this programme reflects the growing momentum in UK-India economic and innovation partnerships.”
Mr Iyer also acknowledged MAHE's continued promotion of innovation, entrepreneurship, and international collaboration, while recognising the contribution of the programme's Knowledge Partner, the Bhubaneswar City Knowledge Innovation Cluster Foundation (BCKIC), in strengthening the accelerator's innovation ecosystem.
Since its inception, the UK-India HealthTech Accelerator Programme has emerged as a leading platform for bilateral healthcare innovation. Across four editions, the initiative has attracted nearly 1,000 applications, supported more than 75 HealthTech companies, facilitated tailored UK market immersion programmes for 23 companies and enabled seven startups to establish operations in the United Kingdom. The programme has also generated approximately Pound 32 million in investment activity, while creating employment opportunities and promoting sustained international collaboration to address global healthcare challenges.
Speaking on the significance of hosting the programme, Dr Sharath K. Rao, Vice Chancellor, MAHE, said, "The UK-India HealthTech Accelerator reflects MAHE's commitment to building an innovation ecosystem where academia, healthcare, industry, government, and entrepreneurs work together to address real-world healthcare challenges. Over the past three days, we have witnessed outstanding innovation, meaningful collaborations, and valuable knowledge exchange that will help Indian startups develop globally relevant healthcare solutions. We are proud to partner with the British High Commission and BCKIC in creating opportunities that strengthen India-UK collaboration while advancing healthcare innovation for global impact."
As the Host Institution for the UK-India HealthTech Accelerator Programme (2026-2028), MAHE continues to strengthen its commitment to innovation, entrepreneurship, translational research, and international collaborations.
About Manipal Academy of Higher Education
Manipal Academy of Higher Education (MAHE) is an Institution of Eminence Deemed to be University. MAHE offers over 400 specialisations across the Health Sciences (HS), Management, Law, Humanities & Social Sciences (MLHS), and Technology & Science (T&S) streams through its constituent units at campuses in Manipal, Mangalore, Bengaluru, Jamshedpur, and Dubai. With a remarkable track record in academics, state-of-the-art infrastructure, and significant contributions to research, MAHE has earned recognition and acclaim both nationally and internationally. In 2020, the Ministry of Education, Government of India, awarded MAHE the prestigious Institution of Eminence status. Currently ranked 3rd in the National Institutional Ranking Framework (NIRF) 2025 rankings, MAHE is the preferred choice for students seeking a transformative learning experience and enriching campus life, as well as for national and multinational corporations seeking top talent.
